#USA #Austin #Sports Innovation #OsteoCentric #UnifiMI

OsteoCentric Technologies: Pioneering Orthopedic Innovations

OsteoCentric Technologies, a company focused on revolutionizing orthopedic minimally invasive surgery (MIS), is at the forefront of an emerging movement in the medical field. Recently, it was announced that the company secured a notable investment from the University Hospitals (UH) Haslam Sports Innovation Center, aimed at propelling advancements in orthopedic sports medicine. This milestone highlights their commitment to addressing critical challenges related to bone injuries and stabilization of implants, crucial elements for successful recovery in sports medicine.

Founded in 2015, OsteoCentric Technologies specializes in innovative solutions designed to enhance the sustainability of bone implants and improve patient outcomes. The company's latest achievement involves their flagship product, UnifiMI, a unique MIS Bone Preservation Tapping Technology that allows for improved integration of implants to bone using a proprietary interlocking thread design.

Investment Background

The UH Haslam Sports Innovation Center, established with a generous $20 million donation from Dee and Jimmy Haslam, is dedicated to scouting groundbreaking technologies in sports medicine. They provide support for innovations that not only minimize injury risks but also accelerate patient recovery. As part of their initiative, OsteoCentric’s UnifiMI technology was chosen because of its significant potential to transform orthopedic procedures.

The Future of Orthopedic Procedures

Dr. James Voos, MD, a distinguished leader in orthopedics and executive director of the Center, noted, "Embracing ever-changing technology like OsteoCentric's UnifiMI not only enhances our ability to repair bones but also paves the way for solutions that foster stability in healing in sports medicine procedures." This sentiment echoes the core mission of the Center, which seeks to integrate advanced solutions into clinical practices.

The UnifiMI technology is recognized for its profound impact due to its ability to:

• - Preserve the natural architecture of the patient’s bone during the implant process.
• - Enhance implant stability over time, minimizing the risk of future complications.
• - Utilize MIS techniques to facilitate a faster healing period for patients.

Industry Implications

Eric Brown, CEO and Founder of OsteoCentric Technologies, expressed pride in receiving this vital investment. He stated, "This investment by UH validates the need for innovation that prioritizes bone preservation and sustaining primary mechanical stability in sports medicine." Such advancements are critical in an industry where the quality of care heavily influences the healing process and long-term outcomes.

With their headquarters located in Austin, Texas, and Logan, Utah, OsteoCentric Technologies continues to lead the charge for innovative orthopedic solutions, guided closely by the insights of top surgeons in the field. The company is dedicated to refining the interface between bone and implant, ensuring better outcomes for patients across the world.

As they prepare to demonstrate the capabilities of UnifiMI at the upcoming American Academy of Orthopaedics 2025 Annual Meeting, the anticipation for its clinical and practical benefits is palpable. For further details on their innovative approach to orthopedic medicine, visit osteocentric.com.